日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial

对新诊断的多转移性尤文氏肉瘤患者采用序贯多模式治疗方法的兴趣:法国前瞻性 CombinaiR3 II 期试验的结果

Laurence, Valérie; Jehanno, Nina; Dureau, Sylvain; Mous, Lieke; Claude, Line; Ballet, Stelly; Pierron, Gaëlle; Gaspar, Nathalie; Brahmi, Mehdi; Valentin, Thibaud; Revon-Rivière, Gabriel; Lervat, Cyril; Probert, Jamie; Entz-Werle, Natacha; Mansuy, Ludovic; Plantaz, Dominique; Rios, Maria; Saumet, Laure; Vérité, Cécile; Castex, Marie-Pierre; Thebaud, Estelle; Cassou-Mounat, Thibaut; Plissonnier, Anne-Sophie; Dieppedale, Jennifer; Delattre, Olivier; Legrier, Marie-Emmanuelle; Marec-Bérard, Perrine; Gouin, François; Berlanga, Pablo; Cordero, Camille; Surdez, Didier; Corradini, Nadège

Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.

从 CIC::DUX4 重排肉瘤中分离出的患者来源的肿瘤样细胞确定 MCL1 为治疗靶点

Breunis Willemijn, Brack Eva, Ehlers Anna C, Bechtold Ingrid, Kisele Samanta, Wurth Jakob, Mous Lieke, Zabele Dorita, Steffen Fabio, Zahnow Felina, Britschgi Christian, Bankel Lorenz, Rothermundt Christian, Vetter Cornelia, Müller Daniel, Botter Sander, Pauli Chantal, Bode Peter, Rinner Beate, Bourquin Jean-Pierre, Roessler Jochen, Grünewald Thomas G P, Schäfer Beat W, Surdez Didier, Wachtel Marco